Search for: "Apotex Inc. v. UCB, Inc."
Results 1 - 19
of 19
Sorted by Relevance
|
Sort by Date
19 Aug 2014, 9:59 pm
Noonan -- Last week, the Federal Circuit affirmed a finding of inequitable conduct in Apotex v. [read post]
17 Aug 2014, 10:00 pm
In Apotex Inc. v. [read post]
15 Dec 2013, 8:24 pm
Apotex Inc. 1:13-cv-02022; filed December 11, 2013 in the District Court of Delaware • Plaintiffs: Pfizer Inc.; UCB Pharma GmbH • Defendant: Apotex Inc. [read post]
18 Aug 2014, 8:56 am
Apotex, Inc. v. [read post]
19 Aug 2014, 3:08 pm
UCB, Inc. ,970 F. [read post]
28 Nov 2014, 8:15 pm
American Honda, Apotex Inc. v. [read post]
19 Aug 2014, 2:09 pm
See Apotex, Inc. v. [read post]
8 Dec 2015, 6:41 am
" Apotex, Inc., et al v. [read post]
24 May 2018, 12:27 am
Apotex, Inc., 480 F.3d 1348,1359 (Fed. [read post]
26 Sep 2014, 9:25 pm
UCB, Inc., No. 13-1674, 2014 WL 3973498, at *8 (Fed. [read post]
11 Sep 2013, 7:07 am
Apotex, Inc., et. al. v. [read post]
25 Aug 2014, 12:00 am
The Federal Circuit has issued a decision in Apotex Inc. v. [read post]
10 Feb 2010, 4:47 pm
Canada (Commissioner of Patents); Monsanto Canada Inc. v. [read post]
27 Jul 2017, 3:16 pm
” Apotex Inc. v. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs) Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd and… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
